Crick — Clinical Intelligence Platform

Large-scale testing (Phase 3)Looking for participantsNCT06694740

What this trial is testing

Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo

Who this might be right for

Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C

Assistance Publique - Hôpitaux de Paris

Results for “After-hours Care”

The (Cost-)Effectiveness of Physician Assistants Working at the Primary Out of Hours Emergency Service

Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit

Screening for Postpartum Depression Using EPDS and HAM-D in Mothers Within 72 Hours After Delivery at a Tertiary Care Center (SOS-Mamma Study)

Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear

Advanced Wireless Sensors for Neonatal Care in the Delivery Room

Better Antibiotic Prescribing Through Action Research

One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

CHASE : aCcelerated 23-Hour erAS Care for Colorectal Surgery

Children With Fever and Respiratory Symptoms at Out-of-hours Services in Norway

The (Cost-)Effectiveness of Nurse Practitioners Working at the Primary Out of Hours Emergency Service

Evaluating the CAREchart@Home™ Program for Enhancing After-hours Cancer Care

Sonographic Evaluation of Diaphragmatic Function in Critical Care Patients With Use of Non Invasive Ventilation

Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents Used for Acute Respiratory Distress Syndrome After Cardiothoracic Surgery

Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo

Differentiated Access to Out-of-hours Primary Care Through Emergency Access

Optimizing Management and Medication of Febrile Children in Out-of-hours Primary Care: CHILI Cluster RCT

Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

Clinical Trial to Assess the Safety of Reducing the Time of Bed Rest After Cardiac Catheterization